105 results on '"Lennard, Andrew"'
Search Results
2. Structured content and data management—enhancing acceleration in drug development through efficiency in data exchange
3. Risk-based approach to setting sterile filtration microbial bioburden limits – Focus on biotech-derived products
4. Stability modeling methodologies to enable earlier patient access
5. Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory
6. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory
7. Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines
8. The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management
9. Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies
10. Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies
11. Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology Industries
12. Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe—An EFPIA View
13. Emotionally taxing
14. Fair value and the Conceptual Framework
15. Compliance and Regulatory Considerations for the Implementation of the Multi-Attribute-Method by Mass Spectrometry in a Quality Control Laboratory
16. Risk-Based Approach to Setting Sterile Filtration Microbial Bioburden Limits – Focus on Biotech-Derived Products
17. Perspectives on the Financial Reporting of Intangibles.
18. The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management
19. PERSPECTIVES ON THE FINANCIAL REPORTING OF INTANGIBLES
20. Liabilities and how to account for them
21. Accounting for intangible assets: suggested solutions
22. Accounting for intangible assets: suggested solutions.
23. The Case for Entry Values: A Defence of Replacement Cost
24. Value and profit; an introduction to measurement in financial reporting
25. Between a rock and a hard place?
26. Rac-1 Regulates Nuclear Factor of Activated T Cells (NFAT) C1 Nuclear Translocation in Response to Fc[small element of] Receptor Type 1 Stimulation of Mast Cells
27. Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals
28. The financial reporting of pensions: time for a review? The Accounting Standards Board believes that a fundamental review of financial reporting for pensions is needed. Their recently published Discussion Paper on the subject contains controversial new proposals as Andrew Lennard, Director of Research at the ASB, explains
29. lnterleukin-1 Receptor Antagonist
30. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
31. The Reporting of Income and Expense and the Choice of Measurement Bases
32. Between a Rock and a Hard Place?
33. Response of the EAA Financial Reporting Standards Committee to the IASB Discussion PaperA Review of the Conceptual Framework for Financial Reporting
34. Pensions
35. FRS poses no new threat to leases
36. Response of the EAA Financial Reporting Standards Committee to the IASB Discussion Paper A Review of the Conceptual Framework for Financial Reporting.
37. Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals
38. Identification of residues which regulate activity of the STE20-related kinase hMINK
39. An international collaboration on future events
40. Debt, equity or something else? The Accounting Standards Board's latest FRED tackles capital instruments
41. Accounting for capital instruments
42. Rac-1 Regulates Nuclear Factor of Activated T Cells (NFAT) C1 Nuclear Translocation in Response to Fcε Receptor Type 1 Stimulation of Mast Cells
43. 3-(13-Hydroxytridecyl)-1-[13-(3-Pyridyl)Tridecyl] Pyridinium Chloride (YM-53792), a Novel Inhibitor of NF-AT activation
44. lnterleukin-1 Receptor Antagonist
45. The Surf-1 and Surf-2 Genes and Their Essential Bidirectional Promoter Elements Are Conserved Between Mouse and Human
46. Future planning
47. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene
48. The Bidirectional Promoter of the Divergently Transcribed Mouse Surf-1 and Surf-2 Genes
49. Stewardship and the Objectives of Financial Statements: A Comment on IASB's Preliminary Views on an Improved Conceptual Framework for Financial Reporting: The Objective of Financial Reporting and Qualitative Characteristics of Decision-Useful Financial Reporting Information
50. Classifying leases: more guidance needed
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.